The SOPHiA DDM health data analysis platform can be found in Microsoft Azure platforms. Through this agreement, we are expanding and reinforcing data-driven medicine through the use of the SOPHiA DDM™ health data analysis platform.
As a software company that specializes in the healthcare industry, SOPHiA GENETICS has made a two-year joint investment with Microsoft to improve precision medicine and patient outcomes. This partnership will lead the development of next-generation healthcare technologies across cloud environments, as well as enable efforts to empower patients so they can take an active role in their wellness.
SOPHiA DDM™️ will help healthcare providers advance medical data research and patient care while relying on the Microsoft Azure platform to keep our systems safe.
SOPHiA DDM is a comprehensive system that makes data-driven medicine possible through its Microsoft Azure compatible cloud platform.
SOPHiA GENETICS’ global network breaks down data silos, allowing for the democratization of data-driven medicine by setting up partnerships with institutions that leverage diverse multimodal data sets on the SOPHiA DDM™ Platform. Although multimodal healthcare data sets are typically the largest and most complex to organize, analyze, and archive, these wide-ranging partnerships will help drive results, improve performance, and ultimately enhance medicine globally in an effort to make precision medicine a reality.
Microsoft’s scale and the power of the SOPHiA DDM Platform was a perfect match for SOPHiA GENETICS, and this partnership will help with clinical outcomes and make patient care more efficient. Jurgi Camblong, PhD., Co-Founder and CEO at SOPHiA GENETICS, says this partnership will “help improve clinical outcomes and make patient care more efficient.” Jurgi Camblong had this to say about working with Microsoft: “SOPHiA GENETICS will help accelerate the transition to a decentralized care model for hospitals, healthcare providers and biopharma by breaking down data silos and delivering innovation at scale.”
“SOPHiA GENETICS’ mission is to democratize data-driven medicine. Microsoft supports this mission by providing secure and scalable cloud infrastructure, alongside SOPHiA GENETICS’ advanced artificial intelligence and machine-learning tools and technologies that can help generate actionable insights, which can lead to better health outcomes,” said David C. Rhew, M.D., global chief medical officer of software company Microsoft.
Microsoft and SOPHiA GENETICS have expanded their collaboration with SOPHiA DDM Platform, powered by artificial intelligence and machine learning, available on Azure. With this new move, medical providers will have the ability to aggregate data and extract insights within their existing workflows. One of Microsoft’s chosen partners for precision medicine, SOPHiA GENETICS will help to accelerate the transition to decentralized care in hospitals, healthcare providers and biopharma by breaking down data silos and delivering innovation at scale.
The products mentioned in this article may or may not be available in your country. The information in this press release relates to products that are approved and available in different countries, which is subject to governmental regulatory body approval. Please contact our customer support team if you need product-specific advice.
About Us
SOPHiA GENETICS is a data-driven platform for the life sciences industry. It allows for complex data analysis and insights from different diagnostic modalities and its primary purpose is to establish data-driven medicine as the standard of care. It’s currently in use by hospitals, labs, and biopharmas around the world. For more information, please visit SOPHiAGENETICS.COM
SOPHiA GENETICS can’t be sure what the future might bring, but we’ve always been on the forefront of functional genomics.
Statements made in this press release may be forward-looking statements. All statements other than statements of historical facts are forward-looking, including our future results and financial position, business strategy, plans and objectives of management. Such forward-looking statements can be subject to risks and uncertainties that may cause actual results to differ materially from those projected in the forward-looking statements. No assurance can be given that such future results will be achieved. These quotes may not be refreshed as they are generated directly from the original source when sent to us.
